COVIDcast - Tocilizumab
FOAMcast - An Emergency Medicine Podcast
English - October 25, 2020 02:30 - 20 minutes - 36.9 MB - ★★★★★ - 222 ratingsMedicine Health & Fitness Education Courses covid covidcast emergency foam foamed medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: COVIDcast: Monoclonal Antibodies
Next Episode: Cannabinoid Hyperemesis Syndrome
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear*
Monoclonal antibodies have received significant attention over the past month and we previously podcasted on antibodies that target SARS-CoV-2. In this episode, we review several recent studies on a different "mab", tocilizumab, which targets inflammation mediated by interleukin-6 that is overly ramped up.
We review:
Stone et al ( RCT)
Salvarani et al. (RCT)
STOP-COVID (observational)
Show notes (references/graphics): FOAMcast.org
Thanks for listening,
Lauren Westafer and Jeremy Faust